SCHEMBL30523331

SCHEMBL30523331

COc1ccc(CN(Cc2ccc(OC)cc2)c2ncnn3c(-c4cnn(-c5cc(N)ccc5C)c4)ccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 6/20 0.36
▸ BCR P11274 6/20 0.36
▸ NOS1 P29475 1/20 0.34
▸ PDE2A O00408 2/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ EGLN2 Q96KS0 1/20 0.31
▸ PDE1B Q01064 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30523358 0.88 ABL1 (0.35) ABL1BCRNOS1PDE2ACHRM4
SCHEMBL30523353 0.78 PDE1B (0.35) NOS1PDE2ACHRM4PDE1B
SCHEMBL29921888 0.78 ABL1 (0.46) ABL1BCR
SCHEMBL30523344 0.74 ROCK2 (0.38) NOS1PDE2AEGFRCSF1RMEN1
SCHEMBL29921458 0.74 ABL1 (0.47) ABL1BCRCSF1RALDH1A1GAA
SCHEMBL29921607 0.71 ABL1 (0.37) ABL1BCR
SCHEMBL19280469 0.69 PDE1B (0.42) NOS1PDE2AMEN1KMT2AALDH1A1
SCHEMBL30678373 0.67 HDAC1 (0.40) PDE2ACHRM4EGFRMEN1KMT2A
SCHEMBL30598755 0.66 PTPN1 (0.40) L3MBTL1ALDH1A1KDM4EPDE1BLMNA
SCHEMBL19701834 0.65 CSF1R (0.41) NOS1PDE2ACSF1RMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761801-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-09-15 — — CN disclosed
Send feedback